# Sclavo, Inc.

- Location (FDA's records): Wayne, NJ
- FDA decisions: 82 (1977–1992): 82 510(k) clearances
- Product codes: CHH (4), CGS (3), JFJ (3), DIH (3), JQB (2), CFJ (2), CDT (2), JJT (2), JJE (2), CEO (2), CHJ (2), CIC (2)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K914789: Elisa CMV Igm (Mar 4, 1992)
- K914852: Elisa Toxo Igm (Jan 23, 1992)
- K914420: Elisa Rubella Igm (Dec 27, 1991)
- K895943: Normal and Abnormal Control Sera (Dec 27, 1989)
- K895822: Total Bilirubin L.F. (Nov 14, 1989)
- K895847: Creatinine 340 (Enzymatic) (Oct 30, 1989)
- K880199: Cholinesterase - Acetythiocholine Substrate (Jan 27, 1989)
- K873496: Atypical Cholinesterase (Jan 27, 1989)

Source page: https://510kreport.com/company/sclavo